Hans J. Moebius

Hans J. Moebius is a seasoned medical professional and entrepreneur with extensive experience in the pharmaceutical industry. As a Venture Advisor at Andera Partners since December 2024, Moebius currently contributes to strategic investment decisions. Moebius co-founded EXCIVA GmbH in 2016, serving as Chief Medical Officer and participating in various roles including Scientific Advisory Board member, focusing on pre-purposing neuropsychiatric drugs and holding multiple patents. Additionally, Moebius has held senior roles at Athira Pharma since April 2019, securing significant funding through an IPO and post-IPO rounds. Previous positions include Chief Medical Officer at Rodin Therapeutics and TauRx Therapeutics, and VP Clinical Research at FORUM Pharmaceuticals. Moebius has been instrumental in leading clinical R&D initiatives, building teams, and developing innovative therapies across notable companies. Academic credentials include MD and PhD degrees, board certifications in Neurology and Psychiatry, and extensive training in clinical research.